Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Sep 10;27(14):2301-5.
doi: 10.1097/QAD.0b013e328362e832.

Dramatic increase in HIV prevalence after scale-up of antiretroviral treatment

Jaffer Zaidi  1 , Erofili Grapsa, Frank Tanser, Marie-Louise Newell, Till Bärnighausen
Affiliations

Dramatic increase in HIV prevalence after scale-up of antiretroviral treatment

Jaffer Zaidi et al. AIDS. .

Abstract

Objectives: To investigate HIV prevalence trends in a rural South African community after the scale-up of antiretroviral treatment (ART) in 2004.

Methods: We estimated adult HIV prevalence (ages 15-49 years) using data from a large, longitudinal, population-based HIV surveillance in rural KwaZulu-Natal, South Africa, over the period from 2004 (the year when the public-sector ART scale-up started) to 2011. We control for selection effects due to surveillance nonparticipation using multiple imputation. We further linked the surveillance data to patient records from the local HIV treatment program to estimate ART coverage.

Results: ART coverage of all HIV-infected people in this community increased from 0% in 2004 to 31% in 2011. Over the same observation period adult HIV prevalence increased steadily from 21 to 29%. The change in overall HIV prevalence is nearly completely explained by an increase of HIV-infected people receiving ART, and it is largely driven by increases in HIV prevalence in women and men older than 24 years.

Conclusion: The observed dramatic increase in adult HIV prevalence can most likely be explained by increased survival of HIV-infected people due to ART. Future studies should decompose HIV prevalence trends into HIV incidence and HIV-specific mortality changes to further improve the causal attribution of prevalence increases to treatment success rather than prevention failure.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1. HIV prevalence estimates by sex and age group
The estimates in this figure are imputation-adjusted. The error bars indicate the 95% confidence intervals.
See this image and copyright information in PMC

References

    1. Okware S, Opio A, Musinguzi J, Waibale P. Fighting HIV/AIDS: is success possible? Bulletin of World Health Organization. 2001;79:1113–1120. - PMC - PubMed
    1. Goldberg AB, Fox AM, Gore RJ, Bärnighausen T. Indicators of political commitment to respond to HIV. Sex Transm Infect. 2012;88:e1. - PubMed
    1. Chopra M, Lawn JE, Sanders D, Barron P, Abdool Karim SS, Bradshaw D, et al. Achieving the health Millennium Development Goals for South Africa: challenges and priorities. Lancet. 2009;374:1023–1031. - PubMed
    1. Herbst AJ, Cooke GS, Bärnighausen T, KanyKany A, Tanser F, Newell ML. Adult mortality and antiretroviral treatment roll-out in rural KwaZulu-Natal, South Africa. Bull World Health Organ. 2009;87:754–762. - PMC - PubMed
    1. Mills EJ, Bakanda C, Birungi J, Chan K, Ford N, Cooper CL, et al. Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda. Ann Intern Med. 2011;155:209–216. - PubMed

Publication types

Substances